|Bid||0.9300 x 800|
|Ask||0.9800 x 900|
|Day's Range||0.9300 - 0.9900|
|52 Week Range||0.6800 - 1.7700|
|Beta (3Y Monthly)||1.46|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Boston Business Journal’s ranking of the highest paid tech CEOs is a look at 25 chief executives' total compensation in Massachusetts companies, based on information from proxy statements filed with the Securities and Exchange Commission in spring of this year.
Woburn-based agricultural bioscience company Yield10 needs to secure funding to make it through the year, according to the company’s public filings, and it’s considering different ways to bring in additional capital, the CEO told the Boston Business Journal.
The Zacks Analyst Blog Highlights: MGP Ingredients, Medifast, Ubiquiti Networks, Yield10 Bioscience and Otter Tail
Yield10 Bioscience Inc, formerly known as Metabolix Inc is an agricultural bioscience company. Yield10 Bioscience Inc had annual average EBITDA growth of 54.90% over the past five years. Warning! GuruFocus has detected 5 Warning Signs with YTEN.
A look at the shareholders of Yield10 Bioscience, Inc. (NASDAQ:YTEN) can tell us which group is most powerful. Institutions often own shares in more established companies, while it's not unusualRead More...
Zero-debt allows substantial financial flexibility, especially for small-cap companies like Yield10 Bioscience Inc (NASDAQ:YTEN), as the company does not have to adhere to strict debt covenants. However, it also faces Read More...
Yield10 Bioscience Inc’s (NASDAQ:YTEN): Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The US$12.9m market-cap company’sRead More...